Tolvaptan
Common brands: Samsca, Jynarque, Lasix, Furosemide, Lasix Onyu
Top reporter: Otsuka America Pharmaceutical, Inc.
Vasopressin V2 Receptor Antagonist [EPC]Loop Diuretic [EPC]Aldosterone Antagonist [EPC]Angiotensin 2 Receptor Blocker [EPC]Dihydropyridine Calcium Channel Blocker [EPC]
13,906
Total Reports
8,605
Serious Reports
3,134
Death Reports
30
Reported Reactions
Death Report Ratio: High (22.54%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Tolvaptan.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DEATH | 997 | |
| 2 | THIRST | 860 | |
| 3 | OFF LABEL USE | 850 | |
| 4 | RENAL IMPAIRMENT | 828 | |
| 5 | CARDIAC FAILURE | 802 | |
| 6 | PRODUCT DOSE OMISSION ISSUE | 652 | |
| 7 | WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 504 | |
| 8 | PRODUCT USE IN UNAPPROVED INDICATION | 490 | |
| 9 | UNDERDOSE | 480 | |
| 10 | DEHYDRATION | 460 | |
| 11 | POLLAKIURIA | 453 | |
| 12 | NO ADVERSE EVENT | 439 | |
| 13 | POLYURIA | 434 | |
| 14 | BLOOD CREATININE INCREASED | 432 | |
| 15 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 428 | |
| 16 | NAUSEA | 420 | |
| 17 | PRODUCT USE ISSUE | 387 | |
| 18 | DIARRHOEA | 382 | |
| 19 | PNEUMONIA | 374 | |
| 20 | FATIGUE | 371 | |
| 21 | BLOOD SODIUM DECREASED | 364 | |
| 22 | HYPERNATRAEMIA | 362 | |
| 23 | HEPATIC FUNCTION ABNORMAL | 347 | |
| 24 | DYSPNOEA | 329 | |
| 25 | DIZZINESS | 317 | |
| 26 | DECREASED APPETITE | 316 | |
| 27 | HYPONATRAEMIA | 306 | |
| 28 | HEADACHE | 294 | |
| 29 | BLOOD UREA INCREASED | 290 | |
| 30 | MALAISE | 288 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.